Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis of Venous Thromboembolism”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70
Not applicableStudy completedNCT01139658
What this trial is testing

Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,676
Testing effectiveness (Phase 2)Study completedNCT00331838
What this trial is testing

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 705
Not applicableEnded earlyNCT05819125
What this trial is testing

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Who this might be right for
Venous Thromboembolism
Sanofi 21,000
Testing effectiveness (Phase 2)Study completedNCT00402467
What this trial is testing

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Who this might be right for
Venous Thromboembolism
Bayer 613
Testing effectiveness (Phase 2)Study completedNCT00398216
What this trial is testing

DU-176b in Preventing Blood Clots After Hip Replacement Surgery

Who this might be right for
ThrombosisHip Replacement
Daiichi Sankyo 903
Testing effectiveness (Phase 2)Study completedNCT00306254
What this trial is testing

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Who this might be right for
Venous Thrombosis
Pfizer 1,225
Large-scale testing (Phase 3)WithdrawnNCT00912483
What this trial is testing

Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients

Who this might be right for
Venous Thromboembolism
Azidus Brasil
Post-approval studies (Phase 4)UnknownNCT06020560
What this trial is testing

Study of Low Molecular Weight Heparins

Who this might be right for
AnticoagulantVenous ThromboembolismProphylaxis+1 more
Herlev Hospital 65,000
Not applicableStudy completedNCT02742623
What this trial is testing

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Who this might be right for
Venous Thrombosis and Pulmonary Embolism
Bayer 528
Large-scale testing (Phase 3)UnknownNCT01072955
What this trial is testing

Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass

Who this might be right for
Prevention of Venous Thromboembolism
Azidus Brasil 104
Large-scale testing (Phase 3)UnknownNCT01072747
What this trial is testing

Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass

Who this might be right for
Prevention of Venous Thromboembolism
Azidus Brasil 104
Not applicableEnded earlyNCT00967447
What this trial is testing

Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

Who this might be right for
ThromboembolismArthroplasty, Replacement, Hip
Boehringer Ingelheim 2
Not applicableStudy completedNCT01557725
What this trial is testing

Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty.

Who this might be right for
Thromboembolic EventsPost-operative Bleeding
Rigshospitalet, Denmark 4,924
Large-scale testing (Phase 3)Looking for participantsNCT07005024
What this trial is testing

DOAC - Dosing Options in AntiCoagulation Prophylaxis

Who this might be right for
CancerVTE (Venous Thromboembolism)
University of Vermont 996
Not applicableNot Yet RecruitingNCT07213713
What this trial is testing

Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.

Who this might be right for
Venous ThromboembolismObese Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80
Testing effectiveness (Phase 2)Study completedNCT01344954
What this trial is testing

Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery

Who this might be right for
Prophylaxis of Venous Thromboembolic Events
ThromboGenics 632
Not applicableStudy completedNCT02258958
What this trial is testing

Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection

Who this might be right for
Venous ThrombosisPulmonary EmbolismLung Neoplasms
McMaster University 150
Large-scale testing (Phase 3)Study completedNCT00913120
What this trial is testing

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 610
Large-scale testing (Phase 3)Study completedNCT00721760
What this trial is testing

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 1,003
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation